top of page

Rachel Brown

BROWN, Rachel, née Fuller, American biochemist, 1898-1980. She worked for the NY State Dept of Health from 1926-68. The drug Nystatin was produced by herself and HAZEN. This is an antifungal antibiotic that may be used simultaneously with antibacterial agents. In 1994 the two of them were the first women admitted to the Inventors Hall of Fame. They both worked for the same department but in different cities in NY State. All their collaboration was done by post over some years. A patent was filed, and the royalties were massive, but all were given for medical research. Later other applications of the drug were found, such as treating Dutch elm disease or in rust prevention. In 1957, the first woman to receive the Pioneer Chemist Award from the American Institute of Chemists.

Biochemist

Inventor 'Nystatin'

Back To:

Further Reading:

Related further reading...

  • facebook
  • Twitter Clean
  • w-googleplus
IW 0101.png
IW 0201.png
IW 0301.png
IW 0401.png
IW 0501.png
IW 0601.png
IW 0701.png
IW 0801.png
IW 0901.png
IW 1001.png
IW 1101.png
IW 1201.png
IW 1301.png
IW 1401.png

© inventricity.com 2014,2015 - 2016

Warning - We are always delighted to receive information from inventors and companies regarding their wonderful inventions.  However, please do not send us confidential information.  You should not disclose your ideas or inventions before either taking professional advice, or stipulating a binding and specific confidentiality agreement, or filing a patent application at the Intellectual Property Office.  Inventors who disclose the details of their invention before filing will not be able to obtain a valid patent.  This advice applies to any disclosure, no matter how select or reputable the agency.  You should not talk to the press, radio, television or any other media, nor should you enter into competitions/exhibitions, or give lectures/presentations without adequate Intellectual Property Protection.

 

Articles and information produced on this site are concerned with general principles only and should not be construed as specific advice.  Intellectual Property Rights and their commercial development are complex subjects and professional advice should always be sought at the appropriate stage.  Procedures and regulations vary from country to country.  Opinions expressed are those of the individual contributors and not necessarily those of Inventricity.com                                                                                                                                                                                                                                               Disclaimer

bottom of page